Učitavanje...
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
BACKGROUND: Chronic lymphocytic leukemia (CLL) primarily affects older persons who often have coexisting conditions in addition to disease-related immunosuppression and myelosuppression. We conducted an international, open-label, randomized phase 3 trial to compare two oral agents, ibrutinib and chl...
Spremljeno u:
| Izdano u: | N Engl J Med |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4722809/ https://ncbi.nlm.nih.gov/pubmed/26639149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1509388 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|